Leerink Partners Biopharma - Two women lab technicians looking at a computer screen

BIOPHARMA

Fueling Healthcare Innovation

CONTACT US
OUR FOCUS

Committed to Successful Outcomes

One of the Healthcare industry’s most active subsectors, Biopharma draws strong corporate and investor interest in the development of novel medicines to treat significant unmet medical needs. Having a reliable, ongoing source of capital is key to funding the lengthy process of bringing therapies to market.

Investors and corporate clients repeatedly turn to Leerink Partners’ experience and expertise to unlock the growth potential of innovative biopharma companies.

Biopharma DNA strand composition

Recent transactions

$200 Million
Joint Placement Agent
Private Placement
November 2024
$85 Million
Sole Bookrunner
Follow-On
October 2024
$60 Million
Placement Agent
Private Placement
October 2024
$20 Million
Joint Bookrunner
Follow-On
October 2024
View all Transactions
Banner desktop

Partner With Us

Let us help you achieve your strategic,
capital markets, and investment objectives

Contact Us

Our experienced team is happy to assist you. Please complete the form below and we’ll be in touch as soon as possible. *” indicates required fields

This field is for validation purposes and should be left unchanged.